Literature DB >> 912645

Infections in patients with malignant lymphoma treated with combination chemotherapy.

R Feld, G P Bodey.   

Abstract

The records of 360 patients with malignant lymphoma treated with various forms of combination chemotherapy from 1966 to 1974 were reviewed. A total of 181 infections was found in 125 patients. The most frequent types of infection were pneumonia (31%), skin infections (17%), urinary tract infections (13%) and septicemia (11%). An etiologic organism was was identified in 133 infections (73%). The most common causative organisms were bacteria (77%), especially gram-negative bacilli. Viral infections accounted for 18% of the infections with 21 of the 24 being due to herpes zoster. These were more frequently found in patients with Hodgkin's disease (14/21) than in the other lymphomas. Among patients with Hodgkin's disease, 53% treated with COP developed infections compared to only 27% treated with MOPP (p = 0.039). Among patients with non-Hodgkin's lymphoma, infections were more frequent in patients treated with Adriamycin containing combinations than with COP. Neutropenia (i.e. less than 1,000 neutrophils/mm3) was associated with 35% of infections in this study and was seen more often in patients with non-Hodgkin's lymphoma (p = 0.048).

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 912645     DOI: 10.1002/1097-0142(197703)39:3<1018::aid-cncr2820390304>3.0.co;2-n

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Measurement of drug dosage intensity in MVPP therapy in Hodgkin's disease.

Authors:  J A Green; A A Dawson; L F Fell; S Murray
Journal:  Br J Clin Pharmacol       Date:  1980-05       Impact factor: 4.335

2.  Impaired antibody responses to a pneumococcal polysaccharide vaccine in patients with non-Hodgkin's lymphoma in remission.

Authors:  O F Ballester; M Shurafa; H Toben; K S Kumar; C L Burek
Journal:  J Clin Immunol       Date:  1981-04       Impact factor: 8.317

3.  Pneumonia during the treatment of acute leukaemia.

Authors: 
Journal:  Br Med J       Date:  1980-11-08

4.  Septicemia in children with leukemia.

Authors:  Y DeClerck; D DeClerck; G E Rivard; P Benoit
Journal:  Can Med Assoc J       Date:  1978-06-24       Impact factor: 8.262

5.  Efficacy of antimicrobial therapy in experimental rat pneumonia: effects of impaired phagocytosis.

Authors:  I A Bakker-Woudenberg; J Y de Jong-Hoenderop; M F Michel
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

6.  Severe neutropenia and relative dose intensity among patients<65 and ≥65 years with non-Hodgkin's lymphoma receiving CHOP-based chemotherapy.

Authors:  Lee S Schwartzberg; Mansoor Saleh; Sadie Whittaker; Esteban Abella
Journal:  Support Care Cancer       Date:  2014-02-19       Impact factor: 3.603

7.  Circulating neutrophils maintain physiological blood pressure by suppressing bacteria and IFNgamma-dependent iNOS expression in the vasculature of healthy mice.

Authors:  Jonathan Morton; Barbara Coles; Kate Wright; Awen Gallimore; Jason D Morrow; Erin S Terry; Peter B Anning; B Paul Morgan; Vincent Dioszeghy; Hartmut Kühn; Pavlos Chaitidis; Adrian J Hobbs; Simon A Jones; Valerie B O'Donnell
Journal:  Blood       Date:  2008-02-15       Impact factor: 22.113

Review 8.  Epidemiology of infections in cancer patients.

Authors:  Teresa R Zembower
Journal:  Cancer Treat Res       Date:  2014
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.